References
- Davatchi F, Chams-Davatchi C, Shams H, Shahram F, Nadji A, Akhlaghi M, Faezi T, Ghodsi Z, Sadeghi Abdollahi B, Ashofteh F, et al. Behcet’s disease: epidemiology, clinical manifestations, and diagnosis. Expert Rev Clin Immunol. 2017;13(1):57–65. doi:https://doi.org/10.1080/1744666X.2016.1205486.
- Mendes D, Correia M, Barbedo M, Vaio T, Mota M, Gonçalves O, Valente J. Behçet’s disease–a contemporary review. J Autoimmun. 2009;32(3):178–88. doi:https://doi.org/10.1016/j.jaut.2009.02.011.
- Yazici H, Tüzün Y, Pazarli H, Yurdakul S, Ozyazgan Y, Ozdoğan H, Serdaroğlu S, Ersanli M, Ulkü BY, Müftüoğlu AU. Influence of age of onset and patient’s sex on the prevalence and severity of manifestations of Behcet’s syndrome. Ann Rheum Dis. 1984;43(6):783–89. doi:https://doi.org/10.1136/ard.43.6.783.
- Leonardo NM, McNeil J. Behçet’s disease: is there geographical variation? A review far from the silk road. Int J Rheumatol. 2015;2015:945262. doi:https://doi.org/10.1155/2015/945262.
- Pay S, Şimşek İ, Erdem H, Dinç A. Immunopathogenesis of Behçet’s disease with special emphasize on the possible role of antigen presenting cells. Rheumatol Int. 2007;27(5):417–24. doi:https://doi.org/10.1007/s00296-006-0281-6.
- Kaburaki T, Fujino Y, Kawashima H, Merino G, Numaga J, Chen J, Matsushima K. Plasma and whole-blood chemokine levels in patients with Behcet’s disease. Graefes Arch Clin Exp Ophthalmol. 2003;241(5):353–58. doi:https://doi.org/10.1007/s00417-003-0668-y.
- Laing KJ, Secombes CJ. Chemokines. Dev Comp Immunol. 2004;28(5):443–60. doi:https://doi.org/10.1016/j.dci.2003.09.006.
- Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res. 2009;29(6):313–26. doi:https://doi.org/10.1089/jir.2008.0027.
- Sheikine Y, Hansson G. Chemokines and atherosclerosis. Ann Med. 2004;36(2):98–118. doi:https://doi.org/10.1080/07853890310019961.
- Miyazaki S, Matsukawa A, Ohkawara S, Takagi K, Yoshinaga M. Neutrophil infiltration as a crucial step for monocyte chemoattractant protein (MCP)-1 to attract monocytes in lipopolysaccharide-induced arthritis in rabbits. Inflamm Res. 2000;49(12):673–78. doi:https://doi.org/10.1007/s000110050645.
- Tuaillon N, Shen DF, Berger RB, Lu B, Rollins BJ, Chan CC. MCP-1 expression in endotoxin-induced uveitis. Invest Ophthalmol Vis Sci. 2002; 43(5): 1493–98. https://iovs.arvojournals.org/article.aspx?articleid=2123165.
- Liu S, Li N, Zhu Q, Zhu B, Wu T, Wang G, Liu S, Luo Q. Increased serum MCP-1 levels in systemic vasculitis patients with renal involvement. J Interferon Cytokine Res. 2018;38(9):406–12. doi:https://doi.org/10.1089/jir.2017.0140.
- Huang Y, Zhang H, Zhang S, Vitamin SJ. D receptor and monocyte chemoattractant protein-1 expressions in peripheral blood mononuclear cells in patients with systemic lupus erythemaotsus. Nan Fang Yi Ke Da Xue Xue Bao= J South Med Univer. 2020;40(1):99–103. doi:https://doi.org/10.12122/j.1673-4254.2020.01.16.
- Arkema EV, Lu B, Malspeis S, Karlson EW, Costenbader KH. Monocyte chemotactic protein-1 elevation prior to the onset of rheumatoid arthritis among women. Biomark Med. 2015;9(8):723–29. doi:https://doi.org/10.2217/BMM.15.40.
- Park UC, Kim TW, Yu HG. Immunopathogenesis of ocular Behcet’s disease. J Immunol. 2014:2014. doi:https://doi.org/10.1155/2014/653539.
- Boyle AP, Hong EL, Hariharan M, Cheng Y, Schaub MA, Kasowski M, Karczewski KJ, Park J, Hitz BC, Weng S, et al. Annotation of functional variation in personal genomes usingRegulomeDB. Genome Res. 2012;22(9):1790–97. https://doi.org/10.1101/gr.137323.112.
- Ward LD, Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 2012;40(D1):D930–4. doi:https://doi.org/10.1093/nar/gkr917.
- Rovin BH, Lu L, Saxena R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun. 1999;259(2):344–48. doi:https://doi.org/10.1006/bbrc.1999.0796.
- Chen Y, Vaughan RW, Kondeatis E, Fortune F, Graham EM, Stanford MR, Wallace GR. Chemokine gene polymorphisms associate with gender in patients with uveitis. Tissue Antigens. 2004;63(1):41–45. doi:https://doi.org/10.1111/j.1399-0039.2004.00150.x.
- Hou S, Yang P, Du L, Jiang Z, Mao L, Shu Q, Zhou H, Kijlstra A. Monocyte chemoattractant protein–1 −2518 A/G single nucleotide polymorphism in Chinese Han patients with ocular Behçet’s disease. Hum Immunol. 2010;71(1):79–82. doi:https://doi.org/10.1016/j.humimm.2009.09.354.
- Kim SK, Jang WC, Ahn YC, Lee SH, Lee SS, Hur JW. Promoter −2518 single nucleotide polymorphism of monocyte chemoattractant protein-1 is associated with clinical severity in Behçet’s disease. Inflamm Res. 2012;61(6):541–45. doi:https://doi.org/10.1007/s00011-012-0471-5.
- Cho ML, Kim JY, Ko HJ, Kim YH, Kim WU, Cho CS, Kim HY, Hwang SY, The MCP-1. promoter-2518 polymorphism in Behcet’s disease: correlation between allele types, MCP-1 production and clinical symptoms among Korean patients. Autoimmunity. 2004;37(1):77–80. doi:https://doi.org/10.1080/08916930310001609446.
- Weichsler B, Davatchi F, Lehner T, O’duffy JD, Rigby AS. Criteria for diagnosis of Behçet’s disease. Lancet. 1990;335(8697):1078–80. doi:https://doi.org/10.1016/0140-6736(90)92643-V.
- Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol. 2008;61(10):991–96. doi:https://doi.org/10.1016/j.jclinepi.2007.11.010.
- Verma MJ, Lloyd A, Rager H, Strieter RR, Kunkel S, Taub D, Wakefield D. Chemokines in acute anterior uveitis. Curr Eye Res. 1997;16(12):1202–08. doi:https://doi.org/10.1076/ceyr.16.12.1202.5034.
- Dechkum N, Hananantachai H, Patarapotikul J, Ohashi J, Krudsood S, Looareesuwan S, Tokunaga K. Monocyte chemoattractant protein 1 (MCP-1) gene polymorphism is not associated with severe and cerebral malaria in Thailand. Jpn J Infect Dis. 2006;59:239.
- He X, Li Y, Liu Z, Yue X, Zhao P, Hu J, Wu G, Mao B, Sun D, Zhang H, et al. The association between CCL2 polymorphisms and drug-resistant epilepsy in Chinese children. Epileptic Disord. 2013;15(3):272–77. doi:https://doi.org/10.1684/epd.2013.0603.
- Feng WX, Mokrousov I, Wang BB, Nelson H, Jiao WW, Wang J, Sun L, Zhou SR, Xiao J, Gu Y, et al. Tag SNP polymorphism of CCL2 and its role in clinical tuberculosis in Han Chinese pediatric population. PLoS One. 2011;6(2):e14652. doi:https://doi.org/10.1371/journal.pone.0014652.
- Lee JH, Park CS. Gene-Gene interactions among MCP genes polymorphisms in asthma. Allergy Asthma Immunol Res. 2014;6(4):333. doi:https://doi.org/10.4168/aair.2014.6.4.333.
- Chen Z, Yin S, Zheng L, Tang W, Kang M, Wei W, Sui K. Relationship between the monocyte chemo-attractant Protein-1 gene rs1024611 A> G polymorphism and cancer susceptibility: a meta-analysis involving 14,617 subjects. Immunol Invest. 2020:1–7. doi:https://doi.org/10.1080/08820139.2020.1776726.
- Chen S, Deng C, Hu C, Li J, Wen X, Wu Z, Li Y, Zhang F, Li Y. Association of MCP-1-2518A/G polymorphism with susceptibility to autoimmune diseases: a meta-analysis. Clin Rheumatol. 2016;35(5):1169–79. 10.1007.
- Huang Y, Yu H, Cao Q, Deng J, Huang X, Kijlstra A, Yang P. The association of chemokine gene polymorphisms with VKH and Behcet’s disease in a Chinese Han population. Biomed Res Int. 2017;2017:1274960. doi:https://doi.org/10.1155/2017/1274960.